Insights
Research, analysis, and regulatory intelligence.
Expert perspectives on genetic disease — from breakthrough therapies to coverage decisions that shape access to care.
Latest articles.
Regulatory Intelligence
CMS Watch.
Track Medicare coverage decisions, national coverage analyses, and policy changes that affect access to genetic therapies.
View CMS Watch →